lidocaine has been researched along with Diabetic Foot in 7 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Diabetic Foot: Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Sadou Yayé, H | 1 |
| Faucheron, A | 1 |
| Dupont, L | 1 |
| El Kouari, F | 1 |
| Fekkar, A | 1 |
| Bellanger, A | 1 |
| Tilleul, P | 1 |
| Ouyang, J | 1 |
| Ji, X | 1 |
| Zhang, X | 1 |
| Feng, C | 1 |
| Tang, Z | 1 |
| Kong, N | 1 |
| Xie, A | 1 |
| Wang, J | 1 |
| Sui, X | 1 |
| Deng, L | 1 |
| Liu, Y | 1 |
| Kim, JS | 1 |
| Cao, Y | 1 |
| Tao, W | 1 |
| Bogomolov, MS | 1 |
| Slobodianiuk, VV | 1 |
| Agarwal, P | 1 |
| Agrawal, PK | 1 |
| Sharma, D | 1 |
| Baghel, KD | 1 |
| Bühler-Singer, S | 2 |
| Hiller, D | 2 |
| Boateng, B | 1 |
| Albrecht, HP | 2 |
| Seidel, C | 2 |
| Hornstein, OP | 2 |
| Grohmann, G | 1 |
| Pöhlmann, G | 1 |
| Eidner, G | 1 |
7 other studies available for lidocaine and Diabetic Foot
| Article | Year |
|---|---|
Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments.
Topics: Administration, Cutaneous; Anesthetics, Local; Chemistry, Pharmaceutical; Diabetic Foot; Drug Compou | 2020 |
In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment.
Topics: Anesthetics, Local; Animals; Cell Line; Cell Proliferation; Diabetes Mellitus, Experimental; Diabeti | 2020 |
[Treatment of trophic ulsers of different etiology].
Topics: Adult; Anesthetics, Local; Anti-Infective Agents, Local; Arteriosclerosis Obliterans; Bacteria; Diab | 2013 |
Intravenous infusion for the treatment of diabetic and ischaemic non-healing pedal ulcers.
Topics: Adult; Case-Control Studies; Debridement; Diabetic Foot; Female; Foot; Foot Ulcer; Gentamicins; Hepa | 2005 |
[Disordered cutaneous microcirculation in diabetic neuropathic foot ulcer. Is modification by retrograde transvenous perfusion therapy possible?].
Topics: Adult; Aged; Blood Flow Velocity; Chemotherapy, Cancer, Regional Perfusion; Dexamethasone; Diabetic | 1995 |
Disturbances of cutaneous microcirculation in patients with diabetic legs: additional parameters for a new therapeutic concept?
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Dexamethasone; Diabetic Angiopathies; Diabeti | 1994 |
[Optimizing analgesia and procedure of retrograde venous perfusion in treatment of patients with peripheral arterial occlusive diseases].
Topics: Arterial Occlusive Diseases; Diabetic Foot; Humans; Ischemia; Leg; Lidocaine; Mepivacaine; Nerve Blo | 1994 |